US Stock MarketDetailed Quotes

DSNKY DAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I

Watchlist
  • 31.810
  • -0.940-2.87%
Close Mar 28 16:00 ET
60.99BMarket Cap46.24P/E (TTM)

About DAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I Company

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Company Profile

SymbolDSNKY
Company NameDAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111

Company Executives

  • Name
  • Position
  • Salary
  • Sunao Manabe
  • Chairman of the Board and Chief Executive Officer
  • --
  • Masahiko Ohtsuki
  • Director, Senior Executive Officer, Chief Information Officer, Global Management Structure and Head, Global DX and Digital Transformation Management Unit
  • --
  • Hiroyuki Okuzawaa
  • Director, President and Chief Operating Officer
  • --
  • Shoji Hirashima
  • Director, Senior Executive Officer and Head, Japan Business Unit
  • --
  • Takashi Fukuoka
  • Director, Senior Executive Officer and Head, Global Corporate Strategy
  • --
  • Takaaki Nishii
  • Independent Director
  • --
  • Sawako Nohara
  • Independent Director
  • --
  • Kazuaki Kama
  • Independent Director
  • --
  • Yasuhiro Komatsu
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Business Data

Revenue by product

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg